Search Articles
SciClone executives inflated shares by lying about the business, operation and prospects of developing treatments for cancer and infectious diseases in China and other international markets, a derivative investor claims.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.